Previous studies have shown HDAC inhibition had anti-fibrotic effect in various diseases, including renal fibrosis [15], pulmonary Fibrosis [8, 16] and liver fibrosis [17]. This evidence concerns the gene HDAC9 and Hepatic fibrosis.